CN111265722B - Double-layer structured periosteum for diabetic bone repair and preparation method thereof - Google Patents

Double-layer structured periosteum for diabetic bone repair and preparation method thereof Download PDF

Info

Publication number
CN111265722B
CN111265722B CN202010259170.7A CN202010259170A CN111265722B CN 111265722 B CN111265722 B CN 111265722B CN 202010259170 A CN202010259170 A CN 202010259170A CN 111265722 B CN111265722 B CN 111265722B
Authority
CN
China
Prior art keywords
layer
periosteum
double
electrostatic spinning
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010259170.7A
Other languages
Chinese (zh)
Other versions
CN111265722A (en
Inventor
张佩华
高原
付少举
郭虹
孙玮
沈为
王峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Donghua University
Original Assignee
Donghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donghua University filed Critical Donghua University
Priority to CN202010259170.7A priority Critical patent/CN111265722B/en
Publication of CN111265722A publication Critical patent/CN111265722A/en
Application granted granted Critical
Publication of CN111265722B publication Critical patent/CN111265722B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/408Virucides, spermicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to a double-layer structured periosteum for repairing diabetic bones and a preparation method thereof, belonging to the field of biomedical materials. The inner layer of the double-layer structured periosteum is a spongy nanofiber layer with a porous structure, which is formed by blending chitosan/polyvinyl alcohol/calycosin according to a certain proportion, and the outer layer of the double-layer structured periosteum is a poly (p-dioxanone) nanofiber layer, and the double-layer structured periosteum is prepared by compounding through an electrostatic spinning process. The outer layer of the double-layer structure periosteum has proper mechanical properties, can effectively support a bone defect part and prevent other soft tissues from growing in; the inner layer is loose and porous, is suitable for the growth, the attachment and the propagation of osteoblasts, and can play the roles of resisting and inhibiting bacteria, reducing blood sugar and the like. The double-layer periosteum has the composite functions of the inner layer and the outer layer, is beneficial to the growth of osteocytes and the repair of bone tissues, and has the characteristics of simple preparation process and convenience in operation.

Description

Double-layer structured periosteum for diabetic bone repair and preparation method thereof
Technical Field
The invention relates to a double-layer structured periosteum for repairing diabetic bones and a preparation method thereof, belonging to the field of medical materials.
Background
At present, diabetes is one of the most frequent chronic diseases, and patients with diabetes with bone defects caused by trauma, inflammation and the like are increasing. Bone defects are caused by trauma, infection or tumor, surgical debridement from osteomyelitis, and various congenital diseases. Bone defects are more common clinically. Due to the phenomenon of aging of people, which is increasingly aggravated in recent years, and sports injury, congenital malformation or accident wound and the like, large-area bone defect can be caused in China. The prevalence of osteopenia and osteoporosis in diabetic patients is as high as 48-72%. Hyperglycemia can change the biomineralization process of osteoblasts and enhance mineralization, so that the osteoblasts are over-expressed, and differentiation, maturation and function regulation of the osteoblasts and osteoclasts are influenced. Therefore, the search for suitable bone tissue repair materials for diabetic patients has become one of the most troublesome problems facing the field at present.
Clinically, the problems are generally treated by means of medicines, autologous or allogeneic bone transplantation and the like. Little attention is paid to coating a layer of periosteum around the implant material, and then the promotion effect of the periosteum on the bone regeneration microenvironment is discussed. Periosteum is a strong connective tissue envelope that coats the surface of bone except for the joint. Traditionally, the periosteum is divided into a superficial fibrous layer and a deep bone layer, and the fibrous layer is thicker and plays a role in fixing the periosteum and ligaments; the bone layer is closely adjacent to the outer surface of the bone, is arranged loosely and has osteogenesis capacity.
Electrospinning is currently the simplest and most efficient method for preparing nanofibers, but further applications are limited due to the structure of the material itself. At present, a plurality of biological and polymer material combinations have been applied to bone repair materials, such as small intestine submucosa (rich in active factors) stents, silk fibroin and polycaprolactone stents, collagen-coated polycaprolactone films and the like, and the combinations are proved to have certain bone regeneration promoting effects, but lack the effect of realizing periosteum regeneration from the structural and functional aspects.
The periosteum for repairing the diabetic bone needs to have good biocompatibility and bioactivity, also needs to have good mechanical support and isolation effects, is beneficial to differentiation and formation of osteoblasts at the contact surface with the bone, and can promote the climbing growth of osteoblasts with larger diameters. In order to solve the problem, the invention provides a double-layer structure periosteum and a preparation method thereof, which have good mechanical support and are beneficial to the growth of osteoblasts in a climbing manner.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: the existing periosteum scaffold material only has certain effect of promoting bone regeneration and lacks the structure and function required by periosteum regeneration.
In order to solve the problems, the technical scheme of the invention is to provide a preparation method of a double-layer periosteum for diabetic bone repair, which is characterized by comprising the following steps:
step 1, preparing an inner layer, which specifically comprises the following steps:
mixing chitosan and polyvinyl alcohol in a mass percentage of 10-30: adding 90-70 parts of the mixture into 20% acetic acid solution to prepare 10% solution, stirring the solution in a water bath at the temperature of 90 ℃ for more than 12 hours, standing and cooling the obtained solution, adding 5-9 uL of calycosin, and stirring the solution at room temperature for 6 hours to obtain inner-layer electrostatic spinning solution;
an electrostatic spinning device is adopted, a receiving distance is controlled to be 16-18 cm, the voltage is controlled to be 18-20 KV, the liquid flow rate is controlled to be 0.3-0.6 mL/h, a 20G flat needle head is adopted, and the electrostatic spinning solution is subjected to electrostatic spinning under the condition that the relative humidity is less than 50% to obtain an inner-layer nanofiber membrane;
and (2) selecting a glutaraldehyde solution with the concentration of 25% to perform crosslinking treatment on the obtained nanofiber membrane for 1h, then drying the nanofiber membrane for 30min at the temperature of 50 ℃ by using vacuum oven equipment, shearing the crosslinked nanofiber membrane, and adding a solvent with the volume ratio of 20: 80 tert-butanol: in a solvent of water, the nanofiber membrane is controlled: the mass-volume ratio of the tertiary butanol aqueous solution is 1: 200, obtaining a fiber dispersion liquid;
homogenizing the fiber dispersion liquid by a homogenizer for 10min, stirring for 3h at room temperature, transferring the solution into a culture dish, controlling the thickness of the fiber dispersion liquid to be 4-6 mm, pre-freezing for 24h at the temperature of-30 to-20 ℃, and then performing vacuum drying for 48h at the temperature of-10 to 0 ℃ to obtain an inner-layer porous structure spongy nanofiber layer;
step 2, preparing the outer layer and the double-layer structure periosteum:
adding 2.9-3.3 g of poly (p-dioxanone) into 7.1-6.7 mL of dimethylformamide, adding 0.01-0.015 g of sodium dodecyl sulfate, and fully stirring to obtain an outer layer electrostatic spinning solution with the concentration of 29-33%; fixing the inner-layer porous-structure spongy nanofiber layer obtained in the step 1 on a collector of an electrostatic spinning device, coating medical glue on the inner-layer porous-structure spongy nanofiber layer, and performing electrostatic spinning on an outer-layer electrostatic spinning solution by using the electrostatic spinning device under the conditions that the voltage is 18-20 KV, the receiving distance is 16-18 cm, the flow rate of an injection pump is 0.6-0.8mL/h, a 19G needle head and the relative humidity is less than 40% to obtain an outer-layer nanofiber layer, so as to form a double-layer-structure periosteum.
Preferably, the concentration of calycosin is 40 mmol/L.
The invention also provides a double-layer structured periosteum for repairing diabetic bones, which is characterized by comprising an inner layer contacted with a human body bone repairing material and an outer layer compounded with the inner layer through medical glue and an electrostatic spinning process, wherein the inner layer is a spongy nanofiber layer with a porous structure and prepared by blending chitosan/polyvinyl alcohol/calycosin according to a certain proportion, and the outer layer is a poly (p-dioxanone) nanofiber layer.
Preferably, the thickness range of the inner layer is 4-6 mm, and the fineness range of the nano-fibers is 0.27-0.31 μm.
Preferably, the thickness of the outer layer ranges from 0.17 mm to 0.2mm, and the fineness of the nano-fibers ranges from 0.27 μm to 0.34 μm.
Compared with the prior art, the invention has the beneficial effects that:
(1) the inner layer porous structure spongy nanofiber layer has the advantages that: the chitosan can adjust the pH value in vivo to make it reach alkalescence, which effectively improves the utilization rate of insulin and improves the comprehensive performance of the stent by compounding with polyvinyl alcohol. Meanwhile, the calycosin is carried, so that the immunity function can be improved, and the effects of resisting bacteria and inhibiting viruses can be achieved. The scaffold has good biocompatibility and effectively promotes the proliferation and differentiation of osteoblasts. The scaffold has good drug slow-release capacity and antibacterial capacity, overcomes the defects of a single high polymer material sponge scaffold, and the layer has large pores, thereby being beneficial to the growth and climbing of osteoblasts with large diameters.
(2) The outer nanofiber membrane has the advantages that: has excellent degradability, biocompatibility and absorbability, and the degradation product has no toxic or side effect. The rigidity of the mask is similar to that of the cartilage of a human body, and the mask can effectively shield external stress. The aperture is smaller than that of the spongy nanofiber layer of the inner layer, so that the inner layer can be protected to a certain extent while the supporting effect is achieved, and the growth of other soft tissues is prevented.
In conclusion, the double-layer structured periosteum has excellent biodegradability and absorbability, can effectively regulate blood sugar of a focus part and promote growth, differentiation and propagation of osteoblasts, and has good biocompatibility.
Drawings
FIG. 1 is a schematic view of a two-layer periosteal structure of the present invention;
FIG. 2 is a microscopic electron micrograph of the periosteal lining of the bilayer structure;
FIG. 3 is a microscopic electron micrograph of the outer periosteal layer of the bilayer structure.
Reference numerals: 1 — an inner layer; 2-outer layer.
Detailed Description
In order to make the invention more comprehensible, preferred embodiments are described in detail below with reference to the accompanying drawings:
as shown in figure 1, the periosteum of the double-layer structure for repairing the diabetic bone has an inner layer and an outer layer; the inner layer 1 which is contacted with the human bone repair material is a spongy nanofiber layer with a porous structure and formed by blending chitosan/polyvinyl alcohol/calycosin according to a certain proportion; the outer layer 2 is a poly (p-dioxanone) nanofiber layer, and the inner layer 1 and the outer layer 2 are compounded by medical adhesive and an electrostatic spinning process. The preparation method comprises the following steps which are respectively provided according to the embodiments.
Example 1
Step 1: preparation of the inner layer:
mixing Chitosan (CS) and polyvinyl alcohol (PVA) according to the mass percentage of 10: adding 90 into 20% acetic acid solution to obtain 10% solution, stirring in 90 deg.C water bath for more than 12 hr, standing, cooling, adding 5 μ L of 40mmol/L calycosin, and stirring at room temperature for 6 hr to obtain inner layer electrostatic spinning solution;
adopting an electrostatic spinning device, controlling a receiving distance of 16cm, a voltage of 18KV, a liquid flow rate of 0.3ml/h and a 20G flat needle head, and carrying out electrostatic spinning under the condition of relative humidity of 30% to obtain an inner-layer nanofiber membrane;
and (2) selecting a 25% glutaraldehyde solution to perform crosslinking treatment on the obtained nanofiber membrane for 1h, then performing drying treatment for 30min at 50 ℃ through a vacuum oven, shearing the crosslinked nanofiber membrane, and adding a solvent with a volume ratio of 20: 80 tert-butanol: in a solvent of water, the nanofiber membrane is controlled: the mass volume ratio of the tertiary butanol aqueous solution is 1: 200, obtaining a fiber dispersion liquid;
homogenizing the fiber dispersion liquid by a homogenizer for 10min, stirring for 3h at room temperature, transferring the solution into a culture dish, controlling the thickness of the fiber dispersion liquid to be 4mm, pre-freezing for 24h at-30 ℃, and then performing vacuum drying for 48h at-10 ℃ to obtain an inner-layer porous structure spongy nanofiber layer;
step 2: preparing an outer layer and a double-layer structure periosteum:
adding 2.9G of poly (p-dioxanone) (PPDO) into 7.1mL of dimethyl formamide (DMF), adding 0.01G of Sodium Dodecyl Sulfate (SDS) and fully stirring to obtain 29% outer-layer electrostatic spinning solution, fixing the inner-layer porous-structure spongy nanofiber layer obtained in the step 1 on a collector, coating medical glue on the inner-layer porous-structure spongy nanofiber layer, and performing electrostatic spinning under the conditions that the voltage is 18KV, the receiving distance is 16cm, the injection pump flow rate is 0.6mL/h, the 19G needle head and the relative humidity is 30% to obtain the double-layer-structure periosteum.
The thickness of the periosteum inner layer of the double-layer structure is 4mm, and the fineness of the nano-fiber is 0.295 mu m; the thickness of the outer layer is 0.196mm, the fineness of the nano-fiber is 0.258 μm, and the breaking stress is 4.19 MPa.
Example 2
Step 1: preparation of the inner layer:
mixing Chitosan (CS) and polyvinyl alcohol (PVA) in a mass percentage of 20: adding 80 into 20% acetic acid solution to obtain 10% solution, stirring in 90 deg.C water bath for more than 12 hr, standing, cooling, adding 7uL of 40mmol/L calycosin, and stirring at room temperature for 6 hr to obtain inner layer electrostatic spinning solution;
adopting an electrostatic spinning device, controlling a receiving distance of 17cm, a voltage of 19KV, a liquid flow rate of 0.45mL/h and a 20G flat needle head, and carrying out electrostatic spinning under the condition of relative humidity of 30% to obtain an inner-layer nanofiber membrane;
and (2) selecting a glutaraldehyde solution with the concentration of 25% to perform crosslinking treatment on the obtained nanofiber membrane for 1h, then performing drying treatment on the nanofiber membrane for 30min at the temperature of 50 ℃ by using vacuum oven equipment, shearing the crosslinked nanofiber membrane, and adding a solvent with the volume ratio of 20: 80 tert-butanol: in a solvent of water, the nanofiber membrane is controlled: the mass-volume ratio of the tertiary butanol solution is 1: 200, obtaining a fiber dispersion liquid;
homogenizing the fiber dispersion liquid by a homogenizer for 10min, stirring for 3h at room temperature, transferring the solution into a culture dish, controlling the thickness of the fiber dispersion liquid to be 5mm, pre-freezing for 24h at-25 ℃, and then performing vacuum drying for 48h at-5 ℃ to obtain an inner-layer porous structure spongy nanofiber layer;
step 2: preparing an outer layer and a double-layer structure periosteum:
adding 3.1G of poly (p-dioxanone) (PPDO) into 6.9mL of dimethyl formamide (DMF), adding 0.012G of Sodium Dodecyl Sulfate (SDS) and fully stirring to obtain an outer-layer electrostatic spinning solution with the concentration of 31%, fixing the inner-layer porous-structure spongy nanofiber layer obtained in the step 1 on a collector, smearing medical glue on the inner-layer porous-structure spongy nanofiber layer, and then performing electrostatic spinning under the conditions that the voltage is 19KV, the receiving distance is 17cm, the injection pump flow rate is 0.7mL/h, the 19G needle head and the relative humidity is 30% to obtain the double-layer-structure periosteum.
The thickness of the periosteum inner layer of the double-layer structure is 5mm, and the fineness of the nano-fiber is 0.309 mu m; the thickness of the outer layer is 0.189, the fineness of the nano-fiber is 0.286 mu m, and the breaking stress is 4.3 MPa.
Example 3
Step 1: preparation of the inner layer:
mixing Chitosan (CS) and polyvinyl alcohol (PVA) in a mass percentage of 30: 70 adding into 20% acetic acid solution to obtain 10% solution, stirring in 90 deg.C water bath for more than 12 hr, standing, cooling, adding 9 μ L of 40mmol/L calycosin, stirring at room temperature for 6 hr to obtain inner layer electrostatic spinning solution;
adopting an electrostatic spinning device, controlling a receiving distance of 18cm, a voltage of 20KV, a liquid flow rate of 0.6ml/h and a 20G flat needle head, and carrying out electrostatic spinning under the condition of relative humidity of 30% to obtain an inner-layer nanofiber membrane;
and (2) selecting a glutaraldehyde solution with the concentration of 25% to perform crosslinking treatment on the obtained nanofiber membrane for 1h, then performing drying treatment for 30min at the temperature of 50 ℃ through a vacuum oven, shearing the crosslinked nanofiber membrane, and adding a solvent with the volume ratio of 20: 80 tert-butanol: in a solvent of water, the nanofiber membrane is controlled: the mass volume ratio of the tertiary butanol solution is 1: 200, obtaining a fiber dispersion liquid;
homogenizing the fiber dispersion liquid by a homogenizer for 10min, stirring for 3h at room temperature, transferring the solution into a culture dish, controlling the thickness of the fiber dispersion liquid to be 6mm, pre-freezing for 24h at-20 ℃, and then performing vacuum drying for 48h at 0 ℃ to obtain an inner-layer porous structure spongy nanofiber layer;
step 2: preparing an outer layer and a double-layer structure periosteum:
adding 3.3G of poly (p-dioxanone) (PPDO) into 6.7mL of dimethyl formamide (DMF), adding 0.015G of Sodium Dodecyl Sulfate (SDS) and fully stirring to obtain an outer layer electrostatic spinning solution with the concentration of 33%, fixing the inner layer porous structure spongy nanofiber layer obtained in the step 1 on a collector, smearing medical glue on the inner layer porous structure spongy nanofiber layer, and then performing electrostatic spinning under the conditions that the voltage is 20KV, the receiving distance is 18cm, the injection pump flow rate is 0.8mL/h, the 19G needle head and the relative humidity is 30% to obtain the double-layer structure periosteum.
The thickness of the periosteum inner layer of the double-layer structure is 6mm, and the fineness of the nano-fiber is 0.309 mu m; the thickness of the outer layer is 0.201mm, the fineness of the nano-fiber is 0.331 mu m, and the breaking stress is 4.51 MPa.
While the invention has been described with respect to a preferred embodiment, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention. Those skilled in the art can make various changes, modifications and equivalent arrangements, which are equivalent to the embodiments of the present invention, without departing from the spirit and scope of the present invention, and which may be made by utilizing the techniques disclosed above; meanwhile, any changes, modifications and variations of the above-described embodiments, which are equivalent to those of the technical spirit of the present invention, are within the scope of the technical solution of the present invention.

Claims (4)

1. A preparation method of a double-layer structure periosteum for diabetic bone repair is characterized by comprising the following steps:
step 1, preparing an inner layer, which specifically comprises the following steps:
mixing chitosan and polyvinyl alcohol in a mass percentage of 10-30: adding 90-70 parts of the mixture into 20% acetic acid solution to prepare 10% solution, stirring the solution in a water bath at the temperature of 90 ℃ for more than 12 hours, standing and cooling the obtained solution, adding 5-9 uL of calycosin with the concentration of 40mmol/L, and stirring the solution at room temperature for 6 hours to obtain inner-layer electrostatic spinning solution;
an electrostatic spinning device is adopted, a receiving distance is controlled to be 16-18 cm, the voltage is controlled to be 18-20 KV, the liquid flow rate is controlled to be 0.3-0.6 mL/h, a 20G flat needle head is adopted, and the electrostatic spinning solution is subjected to electrostatic spinning under the condition that the relative humidity is less than 50% to obtain an inner-layer nanofiber membrane;
and (2) selecting a glutaraldehyde solution with the concentration of 25% to perform crosslinking treatment on the obtained nanofiber membrane for 1h, then drying the nanofiber membrane for 30min at the temperature of 50 ℃ by using vacuum oven equipment, shearing the crosslinked nanofiber membrane, and adding a solvent with the volume ratio of 20: 80 tert-butanol: in a solvent of water, the nanofiber membrane is controlled: the mass-volume ratio of the tertiary butanol aqueous solution is 1: 200, obtaining a fiber dispersion liquid;
homogenizing the fiber dispersion liquid by a homogenizer for 10min, stirring for 3h at room temperature, transferring the solution into a culture dish, controlling the thickness of the fiber dispersion liquid to be 4-6 mm, pre-freezing for 24h at the temperature of-30 to-20 ℃, and then performing vacuum drying for 48h at the temperature of-10 to 0 ℃ to obtain an inner-layer porous structure spongy nanofiber layer;
step 2, preparing the outer layer and the double-layer structure periosteum:
adding 2.9-3.3 g of poly (p-dioxanone) into 7.1-6.7 mL of dimethylformamide, adding 0.01-0.015 g of sodium dodecyl sulfate, and fully stirring to obtain an outer layer electrostatic spinning solution with the concentration of 29-33%; fixing the inner-layer porous-structure spongy nanofiber layer obtained in the step 1 on a collector of an electrostatic spinning device, coating medical glue on the inner-layer porous-structure spongy nanofiber layer, and performing electrostatic spinning on an outer-layer electrostatic spinning solution by using the electrostatic spinning device under the conditions that the voltage is 18-20 KV, the receiving distance is 16-18 cm, the flow rate of an injection pump is 0.6-0.8mL/h, a 19G needle head and the relative humidity is less than 40% to obtain an outer-layer nanofiber layer, so as to form a double-layer-structure periosteum.
2. A double-layer structured periosteum for diabetic bone repair, which is prepared by the method of claim 1, comprising an inner layer (1) contacting a human bone repair material, and an outer layer (2) compounded with the inner layer (1) through medical glue and an electrostatic spinning process, wherein the inner layer (1) is a spongy nanofiber layer with a porous structure and prepared by blending chitosan/polyvinyl alcohol/calycosin according to a certain proportion, and the outer layer (2) is a poly (p-dioxanone) nanofiber layer.
3. The double-layered periosteum for diabetic bone repair according to claim 2, wherein: the thickness range of the inner layer (1) is 4-6 mm, and the fineness range of the nano-fibers is 0.27-0.31 mu m.
4. The double-layered periosteum for diabetic bone repair according to claim 2, wherein: the thickness range of the outer layer (2) is 0.17-0.2 mm, and the fineness range of the nano-fibers is 0.27-0.34 mu m.
CN202010259170.7A 2020-04-03 2020-04-03 Double-layer structured periosteum for diabetic bone repair and preparation method thereof Active CN111265722B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010259170.7A CN111265722B (en) 2020-04-03 2020-04-03 Double-layer structured periosteum for diabetic bone repair and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010259170.7A CN111265722B (en) 2020-04-03 2020-04-03 Double-layer structured periosteum for diabetic bone repair and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111265722A CN111265722A (en) 2020-06-12
CN111265722B true CN111265722B (en) 2021-08-03

Family

ID=70992068

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010259170.7A Active CN111265722B (en) 2020-04-03 2020-04-03 Double-layer structured periosteum for diabetic bone repair and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111265722B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113171496B (en) * 2021-05-14 2022-03-01 中国人民解放军空军军医大学 Porous PCL/collagen artificial periosteum with oriented drug sustained release function and preparation method thereof
CN114306752A (en) * 2022-01-10 2022-04-12 诺一迈尔(苏州)医学科技有限公司 Sclera repairing support and preparation method thereof
CN115581805A (en) * 2022-10-13 2023-01-10 苏州大学附属第一医院 Preparation method of dam-like two-phase bionic periosteum for promoting bone regeneration

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104474589A (en) * 2014-12-23 2015-04-01 山东国际生物科技园发展有限公司 Guided tissue regeneration membrane as well as preparation method and application thereof
CN106039402A (en) * 2016-07-12 2016-10-26 上海纳米技术及应用国家工程研究中心有限公司 Double-layer periosteum-imitation material and preparation method thereof
CN109847105A (en) * 2019-01-10 2019-06-07 东华大学 A kind of new type nerve catheter holder and its preparation method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2447055B1 (en) * 2002-06-24 2017-12-06 Tufts University Silk biomaterials and methods of use thereof
CN107913435B (en) * 2016-10-10 2022-09-09 北京邦塞科技有限公司 Composite type dura mater (spinal) membrane implant, preparation method and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104474589A (en) * 2014-12-23 2015-04-01 山东国际生物科技园发展有限公司 Guided tissue regeneration membrane as well as preparation method and application thereof
CN106039402A (en) * 2016-07-12 2016-10-26 上海纳米技术及应用国家工程研究中心有限公司 Double-layer periosteum-imitation material and preparation method thereof
CN109847105A (en) * 2019-01-10 2019-06-07 东华大学 A kind of new type nerve catheter holder and its preparation method and application

Also Published As

Publication number Publication date
CN111265722A (en) 2020-06-12

Similar Documents

Publication Publication Date Title
CN111265722B (en) Double-layer structured periosteum for diabetic bone repair and preparation method thereof
US11696974B2 (en) Method for preparing a functionally gradient material for guided periodontal hard and soft tissue regeneration
Tanha et al. G‐CSF loaded nanofiber/nanoparticle composite coated with collagen promotes wound healing in vivo
Chen et al. Silk fibroin combined with electrospinning as a promising strategy for tissue regeneration
EP2340785A1 (en) Artificial dura mater and manufacturing method thereof
CN110195294B (en) Nanofiber membrane with double-load core/shell structure and preparation method thereof
CN109876186B (en) Biomedical degradable double-layer stent for nerve repair and preparation method thereof
CN107648669B (en) Method for constructing vascularized tissue engineering periosteum
GB2484319A (en) Electrospinning fibres comprising honey and biocompatible polymer
WO2008069760A1 (en) Three-dimensional porous hybrid scaffold and manufacture thereof
CN101502671A (en) Method for preparing silk fibroin/ P(LLA-CL) compound nano fiber structure repair stand
WO2020062976A1 (en) Degradable surgical suture with biological activity and preparation method therefor
Fu et al. Research progress of the types and preparation techniques of scaffold materials in cartilage tissue engineering
CN109381732A (en) Electrostatic spinning dressing, preparation method and the application of growth factor-loaded micromolecular inhibitor
CN114225116A (en) Artificial periosteum capable of slowly releasing hyaluronic acid and growth factors and preparation method thereof
Peifen et al. New skin tissue engineering scaffold with sulfated silk fibroin/chitosan/hydroxyapatite and its application
CN1584143A (en) Preparing method for growth factor slow-releasing system for tissue repair
Nijsure et al. Collagen-based scaffolds for bone tissue engineering applications
CN113975469B (en) Electrostatic spinning sandwich-like silk fibroin composite nanofiber membrane and preparation method thereof
EP1609492B1 (en) Molded elastin article and process for producing the same
Yu et al. Features of a simvastatin‑loaded multi‑layered co‑electrospun barrier membrane for guided bone regeneration
CN113730041A (en) Double-layer guide bone regeneration support and preparation method thereof
CN114099775A (en) HAp-SF artificial periosteum loading SDF-1 alpha/CGRP and preparation method thereof
Ullah et al. Current trends and biomedical applications of resorbable polymers
Gerzson et al. Assessment of the viability of NIH3T3 fibroblast cells cultured in polymer matrices with rhGH

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant